X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Lupin Ltd Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Lupin Ltd Quarterly Results   (LUPL)

Here are the latest quarterly results of Lupin Ltd. For more details, see the Lupin Ltd financial fact sheet and Lupin Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Lupin Ltd Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-17
3
Sep-17
3
Dec-17
3
Mar-18
3
Jun-18
3
Sep-18
*
3
Dec-18
*
3
Mar-19
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m24,99325,80025,31324,77625,79139,51145,04944,063 
Other income Rs m2797432405321,7252,307434865 
Turnover Rs m25,27226,54325,55225,30827,51641,81745,48344,928 
Expenses Rs m19,55920,38520,33120,23220,77834,01437,52335,340 
Gross profit Rs m5,4345,4154,9824,5455,0145,4964,1038,677 
Depreciation Rs m9519549921,0021,0452,6552,7982,808 
Interest Rs m62106679672738798855 
Profit before tax Rs m4,7005,0984,1623,9795,6224,4109425,879 
Tax Rs m1,1591,2091,0701,0541,3271,7292,4782,998 
Profit after tax Rs m3,5413,8893,0922,9254,2952,681-1,5362,881 
Gross profit margin %21.721.019.718.319.413.99.119.7 
Effective tax rate %24.723.725.726.523.639.2263.051.0 
Net profit margin %14.215.112.211.816.76.8-3.46.5 
Diluted EPS Rs 7.8 8.6 6.9 6.5 9.5 5.9 -3.4 6.4  
Diluted EPS (TTM) Rs 45.0 39.0 31.8 29.8 31.5 28.8 18.5 18.4  
 Subscriber Feature View View View            
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Lupin Ltd 4QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   ALEMBIC PHARMA  WOCKHARDT  PLETHICO PHARMA  AMAR REMEDIES  TTK HEALTHCARE  

Compare LUPIN With:   ALEMBIC PHARMA  WOCKHARDT  PLETHICO PHARMA  AMAR REMEDIES  TTK HEALTHCARE  

Compare LUPIN With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Modi's Victory Creates Sensex History; Ache Din Ahead?(Podcast)

Throughout the week, one slogan that took over the market and country as a whole was, Ab ki baar phir Modi Sarkar.

Views on news

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


May 24, 2019 (Close)

TRACK LUPIN

LUPIN - TEVA PHARMA COMPARISON

COMPARE LUPIN WITH

MARKET STATS